CD19 and COVID-19: This is consistent with the results of our previous research that indicated the lower levels of CD3+ T cell, CD4+ T cell, CD8+ T cell, B cell (CD19+) and NK cell (CD16+ 56+) in severe COVID-19 cases and their correlations with the course of those cases [14].